Heart Disease News and Research

Latest Heart Disease News and Research

New technique may reduce recovery time in arrhythmia patients

A surgeon and an electrophysiologist in the Methodist DeBakey Heart & Vascular Center last week worked together to perform a novel, minimally-invasive procedure to treat a common but dangerous arrhythmia in a 61-year-old lawyer from east Texas who has suffered from the condition for months.

4 Feb 2010

HUCB-derived purified and expanded CD133+ cells may show promise in cellular cardiomyoplasty

Researchers at the Pontif-cia Universidade Cat-lica do Paran- and Instituto Carlos Chagas have evaluated the therapeutic potential of purified and expanded CD133+ cells human umbilical cord blood (HUCB)-derived in treating myocardial infarction by intramyocardially injecting them into a rat model. Patients who have high cardiovascular risks have fewer endothelial progenitor cells (EPCs) and their EPCs exhibit greater in vitro senescence.

4 Feb 2010

Study: Generic nifedipine product not bioequivalent to Adalat XL

An extended release generic nifedipine product (Mylan-Nifedipine extended release 60 mg formerly Gen-Nifedipine extended release 60mg, Genpharm ULC) is not bioequivalent to the Canadian originator product, Adalat(R) XL(R), according to the results of a study recently published in the International Journal of Clinical Pharmacology and Therapeutics.

4 Feb 2010

Canadian Institutes of Health Research awards $2.3M for study on integrative biology of inflammatory diseases

A research team led by Dr. John D. Rioux, a researcher at the Montreal Heart Institute (MHI) and professor in the faculty of medicine at the Université de Montréal, has been awarded a grant of more than $2.3 million to finance a major research project on the integrative biology of inflammatory diseases. From among the roughly 70 applications submitted, Dr. Rioux's team is one of six selected by the Canadian Institutes of Health Research to receive the Emerging Team Grant - From Genes to Proteins, Cells, Tissues and Patients.

4 Feb 2010

Organizations across Canada unite as partners to prevent chronic diseases among Canadians

More than 30 organizations from across Canada are uniting as partners in a series of initiatives designed to improve the health of Canadians by preventing chronic disease. A total of $15.5 million is being invested in seven collaborative coalitions addressing such issues as childhood obesity, screening for chronic disease by family doctors, and the unique needs of First Nations communities.

4 Feb 2010

Geisinger Health System and TGen sign research agreement

Geisinger Health System and the Translational Genomics Research Institute today announced the signing of a strategic research agreement that provides a focused look at the gaps in clinical medicine where biomedical research can make a difference.

4 Feb 2010

Sudden infant death syndrome linked to low serotonin levels

Taking the next step in more than 20 years of research, researchers at Children's Hospital Boston have linked sudden infant death syndrome (SIDS) with low production of serotonin in the brainstem, based on a comparison of brainstem samples from infants dying of SIDS compared to brainstems of infants dying from other, known causes.

4 Feb 2010

St. Jude Medical to commence enrollment in IRASE AF trial

St. Jude Medical, Inc. today announced it has received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin enrollment in the IRASE AF (IRrigated Ablation System Evaluation for AF) trial, a multicenter, randomized, single-blind study evaluating the safety and efficacy of the company’s Duo 12 port open irrigated catheter ablation system for treatment of Atrial Fibrillation (AF). AF is the most common cardiac arrhythmia (abnormal heartbeat), affecting an estimated 3.3 million Americans and millions more worldwide.

4 Feb 2010

TGen, Geisinger Health System sign strategic research agreement

The Translational Genomics Research Institute (TGen) and Geisinger Health System today announced the signing of a strategic research agreement that provides for a focused look at the gaps in clinical medicine where biomedical research can make a difference.

4 Feb 2010

Tough economy adds stress to hospitals; Community health centers help fill gaps

Hospitals get mixed marks while many suffer from the effects of the struggling economy. Meanwhile, community health centers increasingly provide more care and help fill in health care gaps.

4 Feb 2010

Inverness Medical Innovations to acquire Kroll's Substance Abuse Testing division

Inverness Medical Innovations, Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has entered into a binding agreement with Kroll Inc., a subsidiary of Marsh and McLennan Companies, Inc. to purchase its Substance Abuse Testing division (Kroll Laboratory Specialists, Inc.), its business unit providing forensic quality substance abuse testing products and services across the United States.

4 Feb 2010

MedCath announces unaudited operating results for first-quarter of fiscal 2010

MedCath Corporation, a healthcare provider focused on high acuity healthcare services, predominately the diagnosis and treatment of cardiovascular disease, today announced its unaudited operating results for its first quarter of fiscal 2010, which ended December 31, 2009.

3 Feb 2010

Major study of perfusion imaging under way to assess value of alternative diagnostic methods

Cardiologists and heart imaging specialists at 15 medical centers in eight countries, and led by researchers at Johns Hopkins, have enrolled the first dozen patients in a year-long investigation to learn whether the subtle squeezing of blood flow through the inner layers of the heart is better than traditional SPECT nuclear imaging tests and other diagnostic radiology procedures for accurately tracking the earliest signs of coronary artery clogs.

3 Feb 2010

Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications

Daiichi Sankyo Company, Limited, announced today that it has initiated a new large-scale pivotal Phase III trial for edoxaban, its investigational oral Factor Xa inhibitor. This new study, called HOKUSAI (pronounced hoe·koo·sigh) VTE, is evaluating the safety and efficacy of edoxaban in reducing recurrent venous thromboembolic (VTE) complications in patients with deep vein thrombosis (DVT) and/or pulmonary embolism (PE).

3 Feb 2010

Inadequate staffing, interrupted rest breaks and retirement benefit changes impact patient care and nurse safety

Washington State Nurses Association (WSNA), representing more than 1,500 registered nurses at Sacred Heart Medical Center, held an informational picket today to highlight issues critical to patient safety. Contract negotiations have stalled over several key issues including the ability to take uninterrupted rest breaks, inadequate nurse staffing levels, and changes to retirement benefits.

3 Feb 2010

Innovative discharge program reduces congestive heart failure readmissions

An innovative discharge program developed by Saddleback Memorial Medical Center combining coordination of hospital and community resources, strong patient education and the IDEAL LIFE Bluetooth-enabled wireless remote health monitoring system has helped to reduce congestive heart failure (CHF) readmissions by 50 percent

3 Feb 2010

Penn Medicine experts available to offer medical insight and commentary during 2010 Winter Olympics

Experts from the University of Pennsylvania School of Medicine are available to offer expert medical insight and commentary during the 2010 Winter Olympics in Vancouver on issues ranging from the effects of performance enhancing drugs to concerns about the spread of novel H1N1, head trauma and more.

3 Feb 2010

Go Red For Women launches nationwide call inviting women to Speak Up about heart disease

Too many women die each year because they are unaware that heart disease is their No. 1 killer. Right now, one in three women die of cardiovascular disease and 90 percent of women have one or more risk factors for developing heart disease in the future.

3 Feb 2010

LExICon study evaluating laser assisted lead removal using Spectranetics laser sheath published

Spectranetics Corporation today announced publication of the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study in the February 9th issue of the Journal of American College of Cardiology.

3 Feb 2010

Apple Valley Medical Center to hold free Heart Failure Community Education Evening

A free Heart Failure Community Education Evening will be held from 6:00 p.m. to 8:00 p.m. on Tuesday, February 9, 2010, at the Apple Valley Medical Center.

3 Feb 2010

Heart Disease News and Research

Latest Heart Disease News and Research

New technique may reduce recovery time in arrhythmia patients

HUCB-derived purified and expanded CD133+ cells may show promise in cellular cardiomyoplasty

Study: Generic nifedipine product not bioequivalent to Adalat XL

Canadian Institutes of Health Research awards $2.3M for study on integrative biology of inflammatory diseases

Organizations across Canada unite as partners to prevent chronic diseases among Canadians

Geisinger Health System and TGen sign research agreement

Sudden infant death syndrome linked to low serotonin levels

St. Jude Medical to commence enrollment in IRASE AF trial

TGen, Geisinger Health System sign strategic research agreement

Tough economy adds stress to hospitals; Community health centers help fill gaps

Inverness Medical Innovations to acquire Kroll's Substance Abuse Testing division

MedCath announces unaudited operating results for first-quarter of fiscal 2010

Major study of perfusion imaging under way to assess value of alternative diagnostic methods

Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications

Inadequate staffing, interrupted rest breaks and retirement benefit changes impact patient care and nurse safety

Innovative discharge program reduces congestive heart failure readmissions

Penn Medicine experts available to offer medical insight and commentary during 2010 Winter Olympics

Go Red For Women launches nationwide call inviting women to Speak Up about heart disease

LExICon study evaluating laser assisted lead removal using Spectranetics laser sheath published

Apple Valley Medical Center to hold free Heart Failure Community Education Evening

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Heart Disease News and Research

Latest Heart Disease News and Research

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Newsletters you may be interested in